Changes in CD4+ T-cells and HIV RNA resulting from combination of anti-TB therapy with Dzherelo in TB/HIV dually infected patients.

Drug Des Devel Ther · 2009 · PMC2761183 · PMID 19920896

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

When study completion results of Dzherelo recipients were compared in terms of accrual of CD4+ lymphocytes with the entry levels, there was a highly significant increase of 34% and 71% in relative and absolute values.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.